MGI
TPST icon

MayTech Global Investments’s Tempest Therapeutics TPST Stock Holding History

MayTech Global Investments’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-769
Closed -$7.38K – 25
2025
Q1 		$7.38K Hold
769
– – ﹤0.01% 23
2024
Q4 		$8.35K Hold
769
– – ﹤0.01% 24
2024
Q3 		$14K Hold
769
– – ﹤0.01% 30
2024
Q2 		$21.9K Buy
+769
New +$33.3K ﹤0.01% 30
2024
Q1 		– Sell
-769
Closed -$44K – 32
2023
Q4 		$44K Buy
+769
New +$36.4K 0.01% 29

Other funds holding TPST

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

MayTech Global Investments's TPST Position: Q2 2025 in Review

MayTech Global Investments sold out of Tempest Therapeutics (TPST) in Q2 2025, closing a stake of 769 shares — an estimated $7.38K sold.

MayTech Global Investments first reported a position in TPST in Q4 2023 and held it in 5 quarters. The position peaked at $44K in Q4 2023. 18 funds tracked by Wall St. Rank hold TPST as of Q2 2025.

  • MayTech Global Investments reported no remaining Tempest Therapeutics position as of Q2 2025 after selling out during the quarter.
  • MayTech Global Investments sold 769 Tempest Therapeutics shares in Q2 2025, an estimated $7.38K.
  • MayTech Global Investments first reported a position in Tempest Therapeutics in Q4 2023 and held it in 5 quarters.
  • MayTech Global Investments's Tempest Therapeutics position peaked at $44K in Q4 2023.
  • 18 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2025.

Based on MayTech Global Investments's 13F filing for Q2 2025, filed 15 Aug 2025.